Back to the search results

Klinikum Frankfurt (Oder) GmbH

Müllroser Chaussee 7
15236 Frankfurt (Oder)

Phone: 0335-548-0
Mail: ed.offmukinilk@fg

http://www.klinikumffo.de
  • Number of beds: 775
  • Number of specialist departments: 28
  • Number of inpatient cases: 21.729
  • Number of partial inpatient cases: 474
  • Number of outpatient cases: 37.445
  • Hospital owners: Klinikum Frankfurt (Oder) GmbH, Tochtergesellschaft der RHÖN-KLINIKUM AG
  • Type of provider: privat
External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
Chronische Herzinsuffizienz

  • Implementation of the minimum quantity agreement
    No participation
No. Explanation
CQ03 Quality assurance measures for the implementation of positron emission tomography (PET) in hospitals for the indications non-small-cell lung cancer (NSCLC) and solid pulmonary nodules
CQ05 Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 1
CQ24 Quality assurance measures for allogeneic stem cell transplantation for multiple myeloma (valid until 30 June 2022)
CQ01 Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: yes
Number Group
179 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
179 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
60 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

  • ID 57711
Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission
  • Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
  • Zubereitung durch pharmazeutisches Personal
  • Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
  • Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
  • Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
  • Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
  • Aushändigung des Medikationsplans
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Training in other healing professions
Comment

Das Klinikum Frankfurt (Oder) gewährleistet die theoretische und praktische Ausbildung.

Comment

Das Klinikum Frankfurt (Oder) gewährleistet die praktische Ausbildung.

Comment

Das Klinikum Frankfurt (Oder) gewährleistet die praktische Ausbildung.

Comment

Das Klinikum Frankfurt (Oder) gewährleistet die praktische Ausbildung.

Comment

Das Klinikum Frankfurt (Oder) gewährleistet die praktische Ausbildung.

Comment

Das Klinikum Frankfurt (Oder) gewährleistet die praktische Ausbildung.

Comment

Das Klinikum Frankfurt (Oder) gewährleistet einen Teil der praktischen Ausbildung.

Angelika Barsch

Ehrenamtliche Patientenfürsprecherin

Müllroser Chaussee 7
15236 Frankfurt (Oder)

Phone: 0335 -548-2493
Mail: ed.offmukinilk@gnuniem.erhi

Kathrin Busch

Patientenbeauftragte

Müllroser Chaussee 7
15236 Frankfurt (Oder)

Phone: 0335 -548-2493
Mail: ed.offmukinilk@gnuniem.erhi

Julia Gerlach

Qualitätsmanagementbeauftragte (QMB)

Müllroser Chaussee 7
15236 Frankfurt (Oder)

Phone: 0335 -548-2490
Mail: ed.offmukinilk@tnemeganamsteatilauq

Jana Pizzaja

QMB

Müllroser Chaussee 7
15236 Frankfurt (Oder)

Phone: 0335 -548-2490
Mail: ed.offmukinilk@tnemeganamsteatilauq

Dr. med. Margret Seewald

Krankenhaushygienikerin

Müllroser Chaussee 7
15236 Frankfurt (Oder)

Phone: 0335 -548-2850
Mail: ed.offmukinilk@eneigyhhk

Dipl.-Pharm. Britta Happ

Leiterin Krankenhausapotheke

Müllroser Chaussee 7
15236 Frankfurt (Oder)

Phone: 0335 -548-2176
Mail: ed.offmukinilk@ekehtopa

Michael Volkmann

Abteilungleitung Technik

Müllroser Chaussee 7
15236 Frankfurt (Oder)

Phone: 0335 -548-2201
Mail: ed.offmukinilk@kinhcet

Ronny Fischer

Abteilungleitung Technik

Müllroser Chaussee 7
15236 Frankfurt (Oder)

Phone: 0335 -548-2201
Mail: moc.ga-mukinilk-neohr@rehcsiF.ynnoR

Müllroser Chaussee 7
15236 Frankfurt (Oder)

Phone: 0335-548-0
Mail: ed.offmukinilk@fg

Dr. rer. medic. Michael Ossadnik

Pflegedirektor

Müllroser Chaussee 7
15236 Frankfurt (Oder)

Phone: 0335 -548-2009
Mail: ed.offmukinilk@gnutieltsneidegelfP

Petra Naumann

Verwaltungsleitung

Müllroser Chaussee 7
15236 Frankfurt (Oder)

Phone: 0335 -548-2001
Mail: ed.offmukinilk@fg

Sebastian Schütz

Verwaltungsleitung

Müllroser Chaussee 7
15236 Frankfurt (Oder)

Phone: 0335 -548-2001
Mail: ed.offmukinilk@fg

Patrick Hilbrenner

Geschäftsführer

Müllroser Chaussee 7
15236 Frankfurt (Oder)

Phone: 0335 -548-2001
Mail: ed.offmukinilk@fg

Dr. med. Thomas Funk

Ärztlicher Direktor

Müllroser Chaussee 7
15236 Frankfurt (Oder)

Phone: 0335 -548-2008
Mail: ed.offmukinilk@rotkeridrehciltzreA

Dr. med. Frank Hoffmann

Ärztlicher Direktor

Müllroser Chaussee 7
15236 Frankfurt (Oder)

Phone: 0335 -548-2008
Mail: ed.offmukinilk@rotkeridrehciltzrea

Yes

IK: 261201061

Location number: 771632000

Old location number: 771632000

Hospital portrait for download